UQCRH

gene
On this page

Also known as QCR6UQCR8

Summary

UQCRH (ubiquinol-cytochrome c reductase hinge protein, HGNC:12590) is a protein-coding gene on chromosome 1p33, encoding Cytochrome b-c1 complex subunit 6, mitochondrial (P07919). Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. It is a common-essential gene (DepMap: required in 100.0% of cancer cell lines).

Enables ubiquinol-cytochrome-c reductase activity. Predicted to be involved in mitochondrial electron transport, ubiquinol to cytochrome c. Located in mitochondrial inner membrane. Implicated in mitochondrial complex III deficiency.

Source: NCBI Gene 7388 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): mitochondrial complex III deficiency, nuclear type 11 (Moderate, GenCC) — +1 more curated relationship
  • GWAS associations: 2
  • Clinical variants (ClinVar): 24 total — 1 pathogenic
  • Phenotypes (HPO): 15
  • Cancer dependency (DepMap): dependent in 100.0% of screened cell lines (common-essential)
  • MANE Select transcript: NM_006004

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:12590
Approved symbolUQCRH
Nameubiquinol-cytochrome c reductase hinge protein
Location1p33
Locus typegene with protein product
StatusApproved
AliasesQCR6, UQCR8
Ensembl geneENSG00000173660
Ensembl biotypeprotein_coding
OMIM613844
Entrez7388

Gene structure

Transcript identifiers

Ensembl transcripts: 19 — 15 protein_coding, 2 retained_intron, 2 nonsense_mediated_decay

ENST00000311672, ENST00000460947, ENST00000486951, ENST00000489056, ENST00000496387, ENST00000851050, ENST00000866773, ENST00000866774, ENST00000911995, ENST00000911996, ENST00000911997, ENST00000911998, ENST00000911999, ENST00000912000, ENST00000912001, ENST00000949408, ENST00000949409, ENST00000949410, ENST00000949411

RefSeq mRNA: 3 — MANE Select: NM_006004 NM_001297565, NM_001297566, NM_006004

CCDS: CCDS30704

Canonical transcript exons

ENST00000311672 — 4 exons

ExonStartEnd
ENSE000019578394630369846303820
ENSE000035393814631015546310316
ENSE000035789194631655246316776
ENSE000037286814630910146309127

Expression profiles

Bgee: expression breadth ubiquitous, 150 present calls, max score 99.90.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 293.6809 / max 4294.2803, expressed in 1824 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
2734291.21811824
27332.46291150

Top tissues by expression

150 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar vermisUBERON:000472099.90gold quality
heart left ventricleUBERON:000208499.74gold quality
apex of heartUBERON:000209899.67gold quality
right atrium auricular regionUBERON:000663199.64gold quality
primary visual cortexUBERON:000243699.63gold quality
heartUBERON:000094899.62gold quality
superior frontal gyrusUBERON:000266199.62gold quality
dorsolateral prefrontal cortexUBERON:000983499.59gold quality
prefrontal cortexUBERON:000045199.58gold quality
frontal cortexUBERON:000187099.56gold quality
frontal lobeUBERON:001652599.56gold quality
cerebellar cortexUBERON:000212999.55gold quality
cerebellar hemisphereUBERON:000224599.55gold quality
cerebellumUBERON:000203799.54gold quality
right frontal lobeUBERON:000281099.54gold quality
Brodmann (1909) area 9UBERON:001354099.54gold quality
cerebral cortexUBERON:000095699.53gold quality
mucosa of transverse colonUBERON:000499199.52gold quality
anterior cingulate cortexUBERON:000983599.52gold quality
right hemisphere of cerebellumUBERON:001489099.52gold quality
hypothalamusUBERON:000189899.49gold quality
rectumUBERON:000105299.48gold quality
nucleus accumbensUBERON:000188299.47gold quality
telencephalonUBERON:000189399.47gold quality
islet of LangerhansUBERON:000000699.44gold quality
adult mammalian kidneyUBERON:000008299.42gold quality
brainUBERON:000095599.42gold quality
substantia nigraUBERON:000203899.42gold quality
thymusUBERON:000237099.42silver quality
monocyteCL:000057699.41gold quality

Single-cell (SCXA)

Detected in 15 experiment(s), a significant marker in 12.

ExperimentMarker?Max mean expression
E-GEOD-89232yes1389.14
E-MTAB-10042yes1250.98
E-MTAB-8410yes46.59
E-MTAB-9467yes35.09
E-MTAB-7316yes25.64
E-CURD-122yes19.40
E-HCAD-9yes17.50
E-MTAB-9221yes16.13
E-HCAD-10yes12.32
E-GEOD-135922yes11.27
E-HCAD-25yes9.76
E-MTAB-10018no4231.77
E-GEOD-125970no50.82
E-MTAB-8271no10.46
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

17 targeting UQCRH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-651-3P99.9473.485177
HSA-MIR-471999.7372.103329
HSA-MIR-1212499.6869.172700
HSA-MIR-582-5P99.4770.792635
HSA-MIR-376A-3P99.0669.171128
HSA-MIR-376B-3P99.0669.171128
HSA-MIR-480198.9669.422096
HSA-MIR-93598.8269.361072
HSA-MIR-7155-5P98.6566.141290
HSA-MIR-4731-3P98.5668.601860
HSA-MIR-431798.4967.09987
HSA-MIR-6819-5P97.9666.591071
HSA-MIR-6737-5P97.7566.541044
HSA-MIR-376C-3P97.6368.881263
HSA-MIR-6812-5P97.5665.391059
HSA-MIR-60097.0766.731259
HSA-MIR-5579-5P96.3268.54730

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 100.0% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 6)

  • These data provide preliminary evidence of the inactivation of UQCRH gene in cancer either by structural rearrangements or epigenetic mechanisms. (PMID:12881716)
  • Results show that UQCRH is overexpressed in hepatocellular carcinoma. (PMID:28332314)
  • UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells. (PMID:32929120)
  • Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer. (PMID:34133843)
  • Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes. (PMID:34750991)
  • Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis. (PMID:38181234)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriouqcrhENSDARG00000059128
mus_musculusUqcrhENSMUSG00000063882
rattus_norvegicusUqcrhENSRNOG00000012550
drosophila_melanogasterUQCR-11LFBGN0050354
drosophila_melanogasterUQCR-11FBGN0260008

Paralogs (1): UQCRHL (ENSG00000233954)

Protein

Protein identifiers

Cytochrome b-c1 complex subunit 6, mitochondrialP07919 (reviewed: P07919)

Alternative names: Complex III subunit 6, Complex III subunit VIII, Cytochrome c1 non-heme 11 kDa protein, Mitochondrial hinge protein, Ubiquinol-cytochrome c reductase complex 11 kDa protein

All UniProt accessions (3): P07919, A0A087WTF2, A0A087X2B9

UniProt curated annotations — full annotation on UniProt →

Function. Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c.

Subunit / interactions. Component of the ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII), a multisubunit enzyme composed of 11 subunits. The complex is composed of 3 respiratory subunits cytochrome b, cytochrome c1 and Rieske protein UQCRFS1, 2 core protein subunits UQCRC1/QCR1 and UQCRC2/QCR2, and 6 low-molecular weight protein subunits UQCRH/QCR6, UQCRB/QCR7, UQCRQ/QCR8, UQCR10/QCR9, UQCR11/QCR10 and subunit 9, the cleavage product of Rieske protein UQCRFS1. The complex exists as an obligatory dimer and forms supercomplexes (SCs) in the inner mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and cytochrome c oxidase (complex IV, CIV), resulting in different assemblies (supercomplex SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)).

Subcellular location. Mitochondrion inner membrane.

Disease relevance. Mitochondrial complex III deficiency, nuclear type 11 (MC3DN11) [MIM:620137] A form of mitochondrial complex III deficiency, a disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. MC3DN11 is an autosomal recessive form characterized by recurrent episodes of severe lactic acidosis, hyperammonemia, hypoglycemia, and encephalopathy. The disease may be caused by variants affecting the gene represented in this entry.

Similarity. Belongs to the UQCRH/QCR6 family.

RefSeq proteins (3): NP_001284494, NP_001284495, NP_005995* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003422Cyt_b-c1_6Family
IPR023184Ubol_cytC_Rdtase_hinge_domDomain
IPR036811Ubol_cytC_Rdtase_hinge_dom_sfHomologous_superfamily

Pfam: PF02320

UniProt features (15 total): helix 4, modified residue 2, disulfide bond 2, transit peptide 1, chain 1, turn 1, region of interest 1, compositionally biased region 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

5 structures.

PDBMethodResolution (Å)
9HZLELECTRON MICROSCOPY2.52
9CG3ELECTRON MICROSCOPY2.96
5XTEELECTRON MICROSCOPY3.4
5XTHELECTRON MICROSCOPY3.9
5XTIELECTRON MICROSCOPY17.4

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P07919-F187.910.69

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 42, 85

Disulfide bonds (2): 37–81, 53–67

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-611105Respiratory electron transport
R-HSA-9865881Complex III assembly

MSigDB gene sets: 252 (showing top): CCAWYNNGAAR_UNKNOWN, MODULE_151, GCM_NPM1, MORF_UBE2I, MORF_HDAC1, HSIAO_HOUSEKEEPING_GENES, TGACCTY_ERR1_Q2, YY1_Q6, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C, GOBP_OXIDATIVE_PHOSPHORYLATION, GOBP_ELECTRON_TRANSPORT_CHAIN, MORF_BUB3, KEGG_HUNTINGTONS_DISEASE

GO Biological Process (5): oxidative phosphorylation (GO:0006119), mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122), aerobic respiration (GO:0009060), cellular respiration (GO:0045333), proton transmembrane transport (GO:1902600)

GO Molecular Function (2): quinol-cytochrome-c reductase activity (GO:0008121), protein binding (GO:0005515)

GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), respiratory chain complex III (GO:0045275), respiratory chain complex (GO:0098803), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Aerobic respiration and respiratory electron transport1
Respiratory electron transport1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
aerobic respiration1
proton motive force-driven ATP synthesis1
aerobic electron transport chain1
mitochondrial ATP synthesis coupled electron transport1
cellular respiration1
energy derivation by oxidation of organic compounds1
monoatomic cation transmembrane transport1
electron transfer activity1
proton transmembrane transporter activity1
oxidoreduction-driven active transmembrane transporter activity1
oxidoreductase activity, acting on diphenols and related substances as donors1
active monoatomic ion transmembrane transporter activity1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
cytochrome complex1
respiratory chain complex1
transmembrane transporter complex1
oxidoreductase complex1
protein-containing complex1
cellular anatomical structure1

Protein interactions and networks

STRING

1827 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
UQCRHUQCR10Q9UDW1947
UQCRHUQCRBP14927905
UQCRHUQCRC1P31930902
UQCRHUQCRQO14949884
UQCRHCYC1P08574880
UQCRHUQCR11O14957820
UQCRHCOX4I1P13073820
UQCRHUQCRC2P22695800
UQCRHNDUFB7P17568799
UQCRHCOX4I2Q96KJ9796
UQCRHUQCRFS1P47985792
UQCRHCOX5AP20674711
UQCRHNDUFB9Q9Y6M9690
UQCRHMT-CYBP00156685
UQCRHCOX7A2P14406678

IntAct

99 interactions, top by confidence:

ABTypeScore
ARL8AUQCRHpsi-mi:“MI:0915”(physical association)0.720
UQCRHARL8Apsi-mi:“MI:0915”(physical association)0.720
UQCRBCOX7A2Lpsi-mi:“MI:0914”(association)0.640
UQCRHCOX7A2Lpsi-mi:“MI:0914”(association)0.640
COQ5COQ9psi-mi:“MI:0914”(association)0.590
ENTREP3UQCRHpsi-mi:“MI:0915”(physical association)0.560
UQCRHRNF24psi-mi:“MI:0915”(physical association)0.560
UQCRHENTREP3psi-mi:“MI:0915”(physical association)0.560
RNF24UQCRHpsi-mi:“MI:0915”(physical association)0.560
UQCRHNDFIP2psi-mi:“MI:0915”(physical association)0.560
PRRG1UQCRHpsi-mi:“MI:0915”(physical association)0.560
UQCRHNDFIP1psi-mi:“MI:0915”(physical association)0.560
UQCRHDCTN6psi-mi:“MI:0914”(association)0.530
FAM131BAURKApsi-mi:“MI:0914”(association)0.530
ERBB3SLC31A1psi-mi:“MI:0914”(association)0.530
SLC39A4TMEM120Bpsi-mi:“MI:0914”(association)0.530
PBXIP1GOLIM4psi-mi:“MI:0914”(association)0.530
GSDMESLC27A2psi-mi:“MI:0914”(association)0.530
PEX19MYO1Dpsi-mi:“MI:0914”(association)0.530
SIRT3psi-mi:“MI:0915”(physical association)0.400
NPM1UQCRHpsi-mi:“MI:0915”(physical association)0.370
NDUFA12NDUFS8psi-mi:“MI:0914”(association)0.350
OTUB1psi-mi:“MI:0914”(association)0.350
OTUB1EPM2Apsi-mi:“MI:0914”(association)0.350

BioGRID (165): FAM189B (Two-hybrid), RNF24 (Two-hybrid), ARL8A (Two-hybrid), UQCRH (Affinity Capture-MS), UQCRH (Affinity Capture-MS), NDUFS4 (Co-fractionation), UQCRH (Co-fractionation), UQCRH (Co-fractionation), UQCRH (Affinity Capture-MS), UQCRH (Affinity Capture-MS), COX7A2L (Affinity Capture-MS), DOCK11 (Affinity Capture-MS), UQCRB (Affinity Capture-MS), PEX19 (Affinity Capture-MS), ACTR10 (Affinity Capture-MS)

ESM2 similar proteins: A0A096LP55, A0A1D8PJT8, A1L243, A1L3N6, A6H767, A9ULB4, P00126, P00429, P05067, P07919, P08592, P12023, P13805, P14854, P23025, P27088, P28656, P36233, P36378, P48504, P55209, P56277, P79307, P99028, Q0P451, Q0VBY0, Q15545, Q28CA1, Q28EB4, Q2HJG8, Q4R374, Q4R5A5, Q4U0Y4, Q53CG4, Q5IS80, Q5M9I5, Q5R4D4, Q5R7L9, Q5RCT0, Q64267

Diamond homologs: A0A096LP55, P00126, P07919, P48504, P99028, Q5M9I5, Q8SPH5, A0A1D8PJT8, Q0WWE3, Q1ZXP3, Q9SJV7

SIGNOR signaling

1 interactions.

AEffectBMechanism
UQCRH“form complex”“CoQ-cytochrome c reductase-Mitochondrial respiratory chain complex III”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 110 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Respiratory electron transport911.0×6e-05

GO biological processes:

GO termPartnersFoldFDR
aerobic respiration615.5×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance13
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1801224NM_006004.4(UQCRH):c.55-527_243+48delPathogenic

SpliceAI

922 predictions. Top by Δscore:

VariantEffectΔscore
1:46303817:GGAG:Gdonor_gain1.0000
1:46303818:GAG:Gdonor_gain1.0000
1:46303818:GAGG:Gdonor_gain1.0000
1:46303819:AGGT:Adonor_loss1.0000
1:46303821:GT:Gdonor_loss1.0000
1:46303822:T:Gdonor_loss1.0000
1:46310141:T:Aacceptor_gain1.0000
1:46310148:A:AGacceptor_gain1.0000
1:46310149:C:Gacceptor_gain1.0000
1:46310150:A:AGacceptor_gain1.0000
1:46310150:ATCAG:Aacceptor_gain1.0000
1:46310151:T:Gacceptor_gain1.0000
1:46310152:CAGG:Cacceptor_loss1.0000
1:46310152:CAGGA:Cacceptor_gain1.0000
1:46310153:A:AGacceptor_gain1.0000
1:46310153:AG:Aacceptor_gain1.0000
1:46310154:G:GAacceptor_gain1.0000
1:46310154:GG:Gacceptor_gain1.0000
1:46310154:GGA:Gacceptor_gain1.0000
1:46310154:GGAT:Gacceptor_gain1.0000
1:46310154:GGATC:Gacceptor_gain1.0000
1:46310278:G:GTdonor_gain1.0000
1:46310312:ATTGC:Adonor_gain1.0000
1:46310313:TTGC:Tdonor_gain1.0000
1:46310314:TGC:Tdonor_gain1.0000
1:46310314:TGCGT:Tdonor_loss1.0000
1:46310315:GC:Gdonor_gain1.0000
1:46310315:GCG:Gdonor_gain1.0000
1:46310315:GCGTA:Gdonor_loss1.0000
1:46310316:CG:Cdonor_loss1.0000

AlphaMissense

599 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:46310230:T:AC53S0.993
1:46310231:G:CC53S0.993
1:46310272:T:AC67S0.993
1:46310273:G:CC67S0.993
1:46310231:G:AC53Y0.991
1:46310273:G:AC67Y0.991
1:46310274:C:GC67W0.990
1:46310272:T:CC67R0.988
1:46310308:G:CD79H0.988
1:46310230:T:CC53R0.987
1:46310297:T:CL75S0.986
1:46310309:A:TD79V0.986
1:46310231:G:TC53F0.985
1:46310273:G:TC67F0.985
1:46310182:T:AC37S0.984
1:46310183:G:CC37S0.984
1:46310294:T:CF74S0.984
1:46310232:T:GC53W0.983
1:46310302:G:CA77P0.983
1:46310309:A:CD79A0.983
1:46310293:T:CF74L0.982
1:46310295:C:AF74L0.982
1:46310295:C:GF74L0.982
1:46310175:A:CR34S0.981
1:46310175:A:TR34S0.981
1:46310182:T:CC37R0.981
1:46310183:G:AC37Y0.981
1:46310285:T:CL71P0.981
1:46310314:T:AC81S0.980
1:46310315:G:CC81S0.980

dbSNP variants (sampled 300 via entrez): RS1000106401 (1:46302431 C>A,G,T), RS1000258252 (1:46308499 G>A), RS1000709907 (1:46313514 A>T), RS1000833304 (1:46307535 T>A,G), RS1000882462 (1:46307195 C>T), RS1001004742 (1:46302306 C>G,T), RS1001034237 (1:46302015 A>C,G), RS1001162734 (1:46303267 G>A,T), RS1001309464 (1:46308886 G>A,C,T), RS1001393337 (1:46314993 C>T), RS1001580919 (1:46302619 G>A,C,T), RS1001821351 (1:46314770 T>C), RS1001822518 (1:46314090 G>GC), RS1001832453 (1:46313833 C>T), RS1002061056 (1:46307712 G>A,C)

Disease associations

OMIM: gene MIM:613844 | disease phenotypes: MIM:620137

GenCC curated gene-disease

DiseaseClassificationInheritance
mitochondrial complex III deficiency, nuclear type 11ModerateAutosomal recessive

ClinGen Gene-Disease Validity (1)

Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.

DiseaseClassificationInheritance
mitochondrial diseaseLimitedAR

Mondo (1): mitochondrial complex III deficiency, nuclear type 11 (MONDO:0859321)

Orphanet (0):

HPO phenotypes

15 total (15 of 15 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0001289Confusion
HP:0001733Pancreatitis
HP:0001942Metabolic acidosis
HP:0001943Hypoglycemia
HP:0001945Fever
HP:0001987Hyperammonemia
HP:0002013Vomiting
HP:0002014Diarrhea
HP:0002027Abdominal pain
HP:0002151Increased circulating lactate concentration
HP:0002788Recurrent upper respiratory tract infections
HP:0008551Microtia
HP:0011463Childhood onset
HP:0011924Decreased activity of mitochondrial complex III

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005951_37Body mass index8.000000e-10
GCST012227_1399Hip circumference adjusted for BMI1.000000e-08

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

42 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Copperaffects cotreatment, decreases expression, increases abundance, affects binding2
Doxorubicinincreases expression, decreases expression2
dicrotophosdecreases expression1
bisphenol Aaffects expression1
arseniteaffects binding, increases reaction1
sodium arsenitedecreases expression1
zinc chromateincreases abundance, increases expression1
ochratoxin Aincreases expression1
acipimoxincreases expression1
beta-methylcholineaffects expression1
arsenic trichloridedecreases expression, increases abundance, affects cotreatment1
chromium hexavalent ionincreases abundance, increases expression1
CD 437decreases expression1
chloropicrinaffects expression1
K 7174decreases expression1
3-(4’-hydroxy-3’-adamantylbiphenyl-4-yl)acrylic aciddecreases expression1
bisphenol AFincreases expression1
Resveratrolaffects cotreatment, decreases expression, increases expression1
Zoledronic Aciddecreases expression1
Arsenic Trioxideincreases expression1
Acetaminophenincreases expression1
Arsenicdecreases expression, increases abundance, affects cotreatment1
Atrazinedecreases expression1
Bilirubindecreases expression1
Cadmiumincreases abundance, increases expression1
Disulfiramaffects binding, decreases expression1
Fluorouracilaffects expression1
Hydrogen Peroxideaffects expression1
Isoniazidincreases expression1
Ivermectindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.